NO138807C - Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine

Info

Publication number
NO138807C
NO138807C NO701471A NO147170A NO138807C NO 138807 C NO138807 C NO 138807C NO 701471 A NO701471 A NO 701471A NO 147170 A NO147170 A NO 147170A NO 138807 C NO138807 C NO 138807C
Authority
NO
Norway
Prior art keywords
markaptotiadiazole
markaptotetrazole
cephalosporine
preparation
therapeutic active
Prior art date
Application number
NO701471A
Other languages
English (en)
Norwegian (no)
Other versions
NO138807B (no
Inventor
Ryan Charles Wilbur
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to NO752700A priority Critical patent/NO138769C/no
Publication of NO138807B publication Critical patent/NO138807B/no
Publication of NO138807C publication Critical patent/NO138807C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO701471A 1969-04-18 1970-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine NO138807C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO752700A NO138769C (no) 1969-04-18 1975-08-01 Mellomprodukt ved fremstilling av cefalosporin-antibiotika

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US817556A US3641021A (en) 1969-04-18 1969-04-18 3 7-(ring-substituted) cephalosporin compounds

Publications (2)

Publication Number Publication Date
NO138807B NO138807B (no) 1978-08-07
NO138807C true NO138807C (no) 1978-11-15

Family

ID=25223346

Family Applications (2)

Application Number Title Priority Date Filing Date
NO701471A NO138807C (no) 1969-04-18 1970-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine
NO781312A NO781312L (no) 1969-04-18 1978-04-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO781312A NO781312L (no) 1969-04-18 1978-04-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporiner

Country Status (24)

Country Link
US (1) US3641021A (nl)
JP (3) JPS4945880B1 (nl)
BR (1) BR6915448D0 (nl)
CH (1) CH540293A (nl)
CS (2) CS185600B2 (nl)
CY (1) CY775A (nl)
DE (1) DE2018600C3 (nl)
DK (1) DK132119C (nl)
ES (1) ES378765A1 (nl)
FI (1) FI51201C (nl)
FR (1) FR2042346B1 (nl)
GB (1) GB1283811A (nl)
IL (1) IL34285A (nl)
LU (1) LU60751A1 (nl)
MY (1) MY7500031A (nl)
NL (1) NL165170C (nl)
NO (2) NO138807C (nl)
OA (1) OA03254A (nl)
PH (1) PH11309A (nl)
PL (1) PL80605B1 (nl)
SE (2) SE377127B (nl)
SU (1) SU378014A3 (nl)
YU (1) YU36528B (nl)
ZA (1) ZA702290B (nl)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932465A (en) * 1970-07-08 1976-01-13 Ciba-Geigy Corporation 3-R-methyl-7-amino-ceph-em-4-carboxylic acid compounds
JPS4948559B1 (nl) * 1970-11-10 1974-12-21
US3855213A (en) * 1971-02-18 1974-12-17 Smith Kline French Lab 3-heterocyclic thiomethyl-cephalosporins
US3867380A (en) * 1971-02-18 1975-02-18 Smithkline Corp 3-Heterocyclic thiomethylcephalosporins
US3987041A (en) * 1970-12-17 1976-10-19 Smithkline Corporation P-hydroxymethylphenylacetamidocephalosporins
YU36967B (en) * 1971-01-18 1984-08-31 Bristol Myers Co Process for the production of antibacterial agents
IE36221B1 (en) * 1971-04-21 1976-09-15 Ciba Geigy Ag Acylamino compounds and a process for their manufacture
US3757014A (en) * 1971-05-07 1973-09-04 Bristol Myers Co Ts 1,3,4 - oxadiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic acid and sal7-(d-(alpha-amino-alpha-pheyle-acetamido)) - 3-(s-(5-hydroxymethyl -
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US3903278A (en) * 1971-11-04 1975-09-02 Smithkline Corp Method of combating enterobacter infections
CA999574A (en) * 1972-06-14 1976-11-09 Smith Kline And French Canada Ltd. 7-hydroxyhalophenylacetamido-3-h heterocyclicthiomethyl cephalosporins
CA1076560A (en) * 1972-06-14 1980-04-29 Smith Kline And French Canada Ltd. 3-heterocyclic thiomethylcephalosporins
US3968226A (en) * 1972-06-14 1976-07-06 Smithkline Corporation 3-Heterocyclic thiomethylcephalosporins as antibacterial agents
US3828037A (en) * 1972-07-20 1974-08-06 Smithkline Corp Trifluoromethylmercaptoacetamidocephalosporins
US3855212A (en) 1972-08-04 1974-12-17 Squibb & Sons Inc Cyanomethylth ioacetylcephalosporins
US3957768A (en) * 1972-11-14 1976-05-18 Smithkline Corporation 3-heterocyclicthiomethylcephalosporins
GB1438872A (en) * 1972-11-17 1976-06-09 Fujisawa Pharmaceutical Co 7-beta-aminoacylamino-3-substituted-3-cephem-4-carboxylic acid derivatives and preparation thereof
YU36970B (en) * 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
AR207752A1 (es) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
AR205537A1 (es) * 1973-05-10 1976-05-14 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de acido 7-substituido fenilglicinamido - 3 - substituido - 3 - cefem - 4 - carboxilicos
US3962230A (en) * 1973-05-11 1976-06-08 Smithkline & French Laboratories, Inc. P-hydroxymethylphenylacetamidocephalosporins
US3879385A (en) * 1973-05-16 1975-04-22 American Home Prod 3-(Alpha-trifluoromethylarylacetamido)-1,4-cyclo(1,-carboxyl)alkylenethio)-azetidin-2-one derivatives
US4000133A (en) * 1973-06-06 1976-12-28 Fujisawa Pharmaceutical Co., Ltd. Substituted 7-styryl-carbonyloxy-acetamido cephalosporanic
US3884914A (en) * 1973-07-05 1975-05-20 Smithkline Corp Mandelamidocephalosporins with improved properties
US3957985A (en) * 1973-07-05 1976-05-18 Smithkline Corporation Mandelamidocephalosporins with improved properties
US4022895A (en) * 1973-08-01 1977-05-10 Smithkline Corporation Substituted phenylglycylcephalosporins
US3957984A (en) * 1973-08-17 1976-05-18 Smithkline Corporation Substituted mercaptoacetamidocephalosporins
US3883520A (en) * 1973-08-17 1975-05-13 Smithkline Corp Substituted mercaptoacetamidocephalosporins
DK674674A (nl) * 1973-12-21 1975-09-08 Glaxo Lab Ltd
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4205166A (en) * 1974-02-20 1980-05-27 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted-3-aminoalkyl-, acylaminoalkyl-, or hydroxyalkyl-substituted heterocyclic thiomethyl-3-cephem-4-carboxylic acid derivatives and preparation thereof
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
JPS5729475B2 (nl) * 1974-04-11 1982-06-23
US3956292A (en) * 1974-04-01 1976-05-11 Eli Lilly And Company 7-(α-FUROYLUREIDOARYL AND CYCLOHEXADIENYLACETAMIDO) CEPHALOSPORIN ANTIBIOTICS
US3925368A (en) * 1974-04-01 1975-12-09 Lilly Co Eli Acylureido substituted cephalosporins
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US3928334A (en) * 1974-06-06 1975-12-23 Bristol Myers Co Process for the production of cefamandole
JPS612674B2 (nl) * 1974-06-20 1986-01-27 Meiji Seika Co
US3928337A (en) * 1974-08-07 1975-12-23 Bristol Myers Co Process for the production of cefamandole
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
BE833640A (fr) * 1974-09-20 1976-03-19 Nouvelles cephalosporines et leur preparation
US4088815A (en) * 1974-09-20 1978-05-09 E. R. Squibb & Sons, Inc. 3-Heterothio-7-ureido cephalosporins
US4018759A (en) * 1974-12-03 1977-04-19 Smithkline Corporation 3-Heterocyclicthiomethylcephalosporins
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
OA05233A (fr) * 1975-02-04 1981-02-28 Fujisawa Pharmaceutical Co Procédé de préparation d'acides (7-acétamido Disubstitue)-3- substitue-3- cephem-4-carboxyliques et nouveaux produits industriels.
JPS51115493A (en) * 1975-03-18 1976-10-12 Smithkline Corp Novel cephalosporine compound
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
US4107440A (en) * 1975-12-15 1978-08-15 Smithkline Corporation Intermediates for preparing substituted phenylglycylcephalosporins
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
US4127716A (en) * 1976-03-08 1978-11-28 E. R. Squibb & Sons, Inc. 3-heterothiomethyl ureido cephalosporins
US4035361A (en) * 1976-03-17 1977-07-12 Eli Lilly And Company Bis-trimethylsilyl cefamandole and process therefor
US4063019A (en) 1976-03-30 1977-12-13 E. R. Squibb & Sons, Inc. [[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin derivatives
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
US4112228A (en) * 1976-07-13 1978-09-05 Bristol-Myers Company 7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives
JPS5321191A (en) * 1976-08-10 1978-02-27 Shionogi & Co Ltd 7-arylmalonamidocephem derivatives
US4144391A (en) * 1977-03-07 1979-03-13 Eli Lilly And Company Cephalosporin displacement reaction
DE2809058A1 (de) * 1977-03-07 1978-09-14 Lilly Co Eli Verfahren zur herstellung von 3-(thiomethyl)cephalosporinen
US4115644A (en) * 1977-09-19 1978-09-19 Eli Lilly And Company Process for preparing pure cefamandole from alkali metal and ammonium salts thereof
AR223653A1 (es) * 1977-09-27 1981-09-15 Toyama Chemical Co Ltd Procedimiento de preparacion del acido 7-(d(-)-alpha-(4-etil-2,3-dioxo-1-piperazinocarboxamido)-alpha-(4-hidroxifenil)acetamido)-3-(5-(1-metil-1,2,3,4-tetrazolil)tiometil)-delta3-cefem-4-carboxilico y su producto de adicion con n,n-dimetilacetamida
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4223135A (en) * 1979-03-19 1980-09-16 Bristol-Myers Company Production of cephalosporins
US4316016A (en) * 1979-03-19 1982-02-16 Bristol-Myers Company Cephalosporin intermediates
US4316017A (en) * 1979-03-19 1982-02-16 Bristol-Myers Company Cephalosporin intermediates
JPS55139387A (en) * 1979-04-19 1980-10-31 Yamanouchi Pharmaceut Co Ltd Novel synthetic method of 7-amino-3-heterocyclic thiomethyl-delta3-carboxylic acids
EP0137227B1 (en) * 1980-09-02 1987-12-16 Asahi Kasei Kogyo Kabushiki Kaisha Process for the preparation of cephalosporin derivatives using novel thioesters
JPS5988490A (ja) * 1982-11-10 1984-05-22 Kyoto Yakuhin Kogyo Kk セフアロスポリン誘導体
US4737492A (en) * 1986-12-31 1988-04-12 Alcon Laboratories, Inc. Sparingly soluble salts of cefamandole, and ophthalmic compositions containing same
JPH0354585U (nl) * 1989-09-29 1991-05-27
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
FR2876379B1 (fr) * 2004-10-08 2008-09-05 Isochem Sa Procede de polymerisation des o-carboxy anhydrides
WO2013057197A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole
WO2013057196A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104193767B (zh) * 2014-08-07 2016-07-06 杭州长典医药科技有限公司 一种头孢孟多酯钠超细粉体制剂及其制备方法

Also Published As

Publication number Publication date
SU378014A3 (nl) 1973-04-17
CS185558B2 (en) 1978-10-31
GB1283811A (en) 1972-08-02
FR2042346B1 (nl) 1973-12-21
JPS5537997B1 (nl) 1980-10-01
JPS5231356B1 (nl) 1977-08-13
CH540293A (de) 1973-08-15
IL34285A0 (en) 1970-06-17
DK132119B (da) 1975-10-27
DE2018600A1 (de) 1970-11-05
FR2042346A1 (nl) 1971-02-12
BR6915448D0 (pt) 1973-03-13
LU60751A1 (nl) 1970-11-17
OA03254A (fr) 1970-12-15
PL80605B1 (nl) 1975-08-30
NL165170B (nl) 1980-10-15
YU99670A (en) 1982-02-25
DE2018600C3 (de) 1975-07-31
YU36528B (en) 1984-02-29
ZA702290B (en) 1971-11-24
MY7500031A (en) 1975-12-31
NO138807B (no) 1978-08-07
JPS4945880B1 (nl) 1974-12-06
NO781312L (no) 1970-10-20
US3641021A (en) 1972-02-08
SE405251B (sv) 1978-11-27
FI51201B (nl) 1976-08-02
NL165170C (nl) 1981-03-16
NL7005519A (nl) 1970-10-20
CY775A (en) 1975-03-01
ES378765A1 (es) 1972-07-16
DK132119C (da) 1976-04-20
DE2018600B2 (de) 1975-01-02
IL34285A (en) 1973-10-25
SE377127B (nl) 1975-06-23
FI51201C (fi) 1976-11-10
CS185600B2 (en) 1978-10-31
PH11309A (en) 1977-11-02

Similar Documents

Publication Publication Date Title
NO138807C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine
SE393381B (sv) Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
FI54301B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat
SE383887B (sv) Analogiforfarande for framstellning av alfa-amino-cyklohexadienyl-alkylen-penicilliner
SE390304B (sv) Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO139127C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkylaminer
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
FI53700C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat
SE403612B (sv) Analogiforfarande for framstellning av antibakteriellt aktiva hexametylen-bis-biguanider
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO137893C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-m-trifluormetylfenyl-2-cyanoalkylaminopropaner
NO139440C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-4h-pyraner